approval
saveGLATOPA (GLATIRAMER ACETATE) — FDA approval
community read0 votes
Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalFeb 12, 2026 · 232d ago
- approvalGLATIRAMER ACETATE — FDA approvalFeb 11, 2026 · 233d ago
- approvalGLATIRAMER ACETATE — FDA approvalFeb 11, 2026 · 233d ago
- approvalGLATIRAMER ACETATE — FDA approvalDec 31, 2025 · 275d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 7, 2025 · 574d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 7, 2025 · 574d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 19, 2024 · 927d ago
- approvalGLATOPA (GLATIRAMER ACETATE) — FDA approvalMar 19, 2024 · 927d ago
same company · ±60 days · 6
- approvalGLATIRAMER ACETATE: GLATOPA (GLATIRAMER ACETATE) — FDA approvalFeb 12, 2026
- approvalaflibercept biosimilar: ENZEEVU (AFLIBERCEPT-ABZV) — FDA approvalFeb 12, 2026
- approvalZOLEDRONIC ACID: RECLAST (ZOLEDRONIC ACID) — FDA approvalFeb 3, 2026
- approvalnatalizumab biosimilar: TYRUKO (NATALIZUMAB-SZTN) — FDA approvalFeb 2, 2026
- approvalUNASYN: AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalJan 30, 2026
- approvalUNASYN: AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalJan 27, 2026
comments(0)
5-min edit window · permanent after that